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Summary 
Inflammation of the  corneal stroma  (stromal keratitis)  is  a  serious complication of infection 
with the nematode parasite Onchocerca volvulus.  Because stromal keratitis is believed to be im- 
munologically mediated in humans, we used a murine model to examine the role ofT cells and 
T  helper cell cytokines in the immunopathogenesis of these eye lesions. BALB/c mice immu- 
nized subcutaneously and injected intrastromally with soluble O. volvulus  antigens (OvAg) de- 
veloped pronounced  corneal  opacification and  neovascularization.  The  corneal stroma  was 
edematous and contained numerous eosinophils and mononuclear cells. Strornal keratitis in im- 
munized mice was determined to be T  cell dependent based on the following observations: (a) 
T  cell-deficient nude mice immunized and injected intrastromally with OvAg fail to develop 
corneal pathology; and  (b)  adoptive transfer of spleen cells from OvAg-immunized BALB/c 
mice  to  naive nude  mice before intrastromal  injection of OvAg results in  development of 
keratitis. OvAg-stimulated lymph node and spleen cell cytokine production was dependent on 
CD4 cells and included interleukin (IL)-4 and IL-5, but not interferon % indicating a predom- 
inant T helper type 2 cell-like response. Inflamed corneas from immunized BALB/c mice and 
from reconstituted nude mice had greatly elevated CD4 and IL-4 gene expression compared 
with interferon ~/. Mice in which the IL-4 gene was disrupted failed to develop corneal disease, 
demonstrating that IL-4 is essential  in the immunopathogenesis of O.  volvulus-mediated  stro- 
real keratitis. 
O 
nchocerciasis is a major cause of blindness in Africa 
and  Latin America.  Approximately 20  million per- 
sons are infected by the causative nematode, Onchocerca vol- 
vulus, and 2% of these individuals are blinded from the dis- 
ease  (1,  2).  In  the  African  savanna,  blindness  due  to 
onchocerciasis is most commonly due to stromal keratitis, 
whereas blindness in rain forest areas is largely due to retin- 
itis  (3, 4).  Clinical observations indicate that the sequence 
of pathologic events in keratitis is initiated when first-stage 
larvae, microfilariae, migrate through the skin into the cor- 
nea.  The  microfflariae  elicit  little  or  no  pathologic  re- 
sponses when alive, but an inflammatory reaction develops 
when the parasites  die either by natural attrition or after ad- 
ministration of chemotherapy (5-7). This is initially charac- 
terized as a punctate keratitis, in which discrete sites of cor- 
neal opacification correlate with the presence of dead and 
degenerating microfilariae. In the more advanced stage  of 
infection, sclerosing keratitis ultimately leads  to permanent 
loss  of vision (5,  8).  This condition is manifest as stromal 
opacification and corneal neovascularization, and histologic 
examination of corneas and conjunctival tissue from chron- 
ically infected individuals  shows  mononuclear cells,  neu- 
trophils, and eosinophils (5, 9). Coupled with the observa- 
tion  that  persons with  onchocerciasis have  elevated Th2 
responses  (10-15),  these  histologic  and  clinical  findings 
provide circumstantial evidence that stromal keratitis is due 
to  host  immune-mediated  inflammatory  reactions.  This 
notion is supported by experimental studies of guinea pigs 
and mice that show that prior sensitization to live microfi- 
lariae or soluble  O.  volvulus  antigens  (OvAg) 1 exacerbates 
stromal keratitis after local injection with the same antigen 
1Abbreviations used in this paper: HPRT,  hypoxanthine phosphoribosyl- 
transferase; LNC, lymph node cell; mRNA, messenger RNA; OvAg, 
Onchocerca volvulus Ag; PPD, purified protein derivative; RT,  reverse 
transcription. 
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T  cells and IL-4 are required for development ofonchocer- 
ca/stromal keratitis in mice. 
Materials  and Methods 
Animals.  Female BALB/c mice weighing 18-20 g were pur- 
chased  from Charles  River Laboratories  (Wilmington, MA).  T 
cell-deficient nude mice on a BALB/c (H-2  a) background were 
obtained from the Ireland Cancer Center (Case Western Reserve 
University, Cleveland, OH). To maintain a relatively germ-free 
environment and to minimize eye irritation resulting from waste 
fumes, nude mice were housed in microisolators at three mice per 
cage. Cages were changed at least twice per week. 
Mice in which the  IL-4 gene had been disrupted  were pro- 
duced by insertion of a neo  r gene into the first exon of the IL-4 
gene as described  by Kopf et al.  (20). These mice were derived 
from  the  F  2 generation  of  129Sv  ￿  C57B1/6  breedings  and 
termed  IL-4  -/-  mice.  Control mice for these  experiments in- 
cluded:  (a)  age-matched wild-type (IL-4 +/+) female  mice from 
the same breedings;  and (b) age-matched female  C57B1/6  mice 
(Charles  River Laboratories).  IL-4  -/-  and IL-4  +/+  mice were 
sent to us by Dr. Ed Pearce (Comell University, New York) with 
kind permission from Dr. Manfred Kopf (Basel Institute for Im- 
munology, Basel, Switzerland)  and were maintained as breeding 
pairs in the animal facilities at Case Western Reserve University. 
The  IL-4  -/-  genotype was  confirmed by amplification  of ge- 
nomic DNA using primers specific for the  neo  ~ and IL-4 genes 
(20). All of the mice designated  IL-4  -/- had neo  r PCR products, 
whereas no neo  r PCR products were detected in genomic digests 
oflL-4  +/+ or C57B1/6 mice. 
Ag Preparations.  OvAg was prepared from onchocercal nod- 
ules  surgically  excised  from West African  patients.  To  remove 
human tissue, nodules were digested with 0.4% collagenase (Boe- 
hringer Mannheim  Biochemical Products, Indianapolis, IN) for 8 h 
at  37~  and  washed  repeatedly  with  PBS,  pH  7.0  (18, 19). 
Worms were then homogenized on ice in a tissue grinder (Ten 
Broeck; Baxter Healthcare  Corp., McGaw Park, IL), and the ho- 
mogenate was centrifuged at 20,000 g for 60 rain. Supematants 
containing  soluble OvAg were passed through a 2-p,m syringe fil- 
ter  (Amicon, Inc., Beverly,  MA),  and protein concentration of 
the supernatant was determined using the bicinchoninic  acid assay 
(Pierce,  Rockford,  IL)  with BSA  as  standard  (Sigma Chemical 
Co., St. Louis, MO). OvAg concentration was adjusted to 1 mg/ 
ml and stored at -70~  Parasites and, in some experiments, sol- 
uble OvAg were kindly provided by Dr. David Freedman (Uni- 
versity  of Alabama,  Birmingham, AL). Mycobacterium  tuberculosis 
purified protein derivative  (PPD)  was obtained from Dr.  Henry 
Boom (Case Western Reserve University). 
Immunization and Intrastromal  Injection.  Mice were given three 
weekly subcutaneous immunizations with 10 Ixg OvAg or PPD 
in 100 Ixl HBSS  (GIBCO BRL, Gaithersburg,  MD) mixed with 
100 I*1 adjuvant consisting of squalene,  Tween 80, and pluronic 
acid  (21, 22).  1 wk after  the final immunization, corneas  were 
scarified using a 30-gauge needle, and  10  Ixg antigen in 10  Ixl 
HBSS was injected into the corneal stroma using a 33-gauge nee- 
dle attached  to  a gas-tight  syringe  (Hamilton Co.,  Reno, NV). 
Successful intrastromal injection was confirmed by the appearance 
of transient corneal clouding followed by reversion to the normal 
transparent state by the next day. This procedure was highly re- 
producible,  and  no  more  than  3  Ixl  of fluid leaked  from  the 
wound. All procedures conformed with resolutions  on the use of 
animals in research determined by the Association for Research in 
Vision and Ophthalmology. 
Clinical and Histological  Evaluation.  Slit lamp microscopy was 
performed,  and keratitis was graded for opacification  and neovas- 
cularization in a masked  fashion as described  previously (18, 23, 
24). Opacification is used in this context as the degree  of corneal 
clouding based  on visibility  of iris detail,  rather than the  strict 
clinical sense of permanent scarring. Photographs  were obtained 
with a vertical  photo-slit lamp microscope (Marco  Ophthalmic 
Inc., Jacksonville,  FL)  using Ektachrome  film  (160T;  Eastman 
Kodak Co., Rochester, NY). 
For histological  examination, eyes  were  removed at  various 
times after OvAg injection and fixed in 10% neutral buffered for- 
malin.  They  were  then  embedded  in  paraffin,  sectioned,  and 
stained with hematoxylin and eosin using standard methods.  Re- 
producibility was attained by aligning the eye such that the cor- 
nea was uppermost and sectioning through the center of the cor- 
nea and pupil. Eosinophils  were identified by the  characteristic 
horseshoe-shaped  nuclei and eosin-staining  granules. 
Lymph  Node  and  Spleen  Ceil  Preparations.  Cell  suspensions 
from spleens or inguinal lymph nodes (LNC)  were prepared  by 
standard aseptic technique. Briefly, erythrocytes  were lysed with 
0.01 M Tris, pH 7.2, containing  0.75% ammonium chloride,  and 
cells were washed  three times  in RPMI 1640 and suspended in 
complete medium (RPMI i640 containing I mM sodium pyru- 
rate,  2  mM  t-glutamine, 20  mM Hepes,  100  U/ml penicillin, 
100 Ixg/ml streptomycin, and 10% heat-inactivated FCS). Dupli- 
cate wells containing 5 X  10  s cells were stimulated with 10 p.g/ 
ml antigen in a final volume of 200 Ixl and incubated at 37~  in 
5% CO2 for 72 h. 
Cell Proliferation and Cytokine and IgE Assays.  After 72 h of in- 
cubation, 150 ~1 culture supernatant was removed for cytokine 
measurements,  and cells were pulsed with 0.1 I~Ci [3H]thymidine 
(Amersham  Corp., Arlington Heights,  IL) for an additional 6  h 
before harvesting onto glass fiber filters (Cambridge Technology, 
Inc., Watertown, MA). Filters were dried and added to 5 ml scin- 
tillation fluid  (EcoScint  A; National Diagnostics,  Inc., Manville, 
NJ), and the number of counts per minute was determined using 
a  beta  scintillation counter  (Beckman  Instruments,  Fullerton, 
CA).  Stimulation index was  calculated  as:  cpm Ag stimulated/ 
cpm unstimulated (22). 
Measurements of IL-4,  IL-5, and IFN-2* in culture superna- 
rants were performed by two-site ELISA as described (22, 25) us- 
ing the following rnAbs: For IL-4, BVD6 was  the coating and 
biotinylated BVD4 was the detecting mAb (obtained from Dr. F. 
Heinzel, Case  Western Reserve  University); for  IL-5,  TRFK5 
was the trapping and TRFK4 was the detecting mAb (obtained 
from Dr. R. Coffman, DNAX, Palo Alto, CA); and for IFN-% 
R46A2  was  the  coating and XMG1.2 was  the  detecting mAb 
(obtained from American Type Culture Collection, Rockville, 
MD).  Cytokines were  measured after  addition of streptavidin- 
peroxidase  and 0-phenylenediamine substrate  (Sigma  Chemical 
Co.), and absorbance was measured at 492 nm in a reader (Multi- 
skan  Plus  MKII; Flow Laboratories,  Inc., McLean,  VA).  Stan- 
dards for the IL-4 and IL-5 ELISAs were generated in culture su- 
pernatants of Con A-stimulated spleen  cells from control mice, 
and recombinant murine IFN-y (Genzyme Corp.,  Cambridge, 
MA) was used as a standard in the IFN-y assay. Total serum IgE 
was detected by two-site ELISA using rat anti-mouse IgE mAbs 
EM95 and BF815 as described (22, 25). 
To deplete CD4 or CD8 cells, 2 ￿  107 spleen cells were incu- 
bated with anti-murine CD4  (GK  1.5) or anti-CD8 (53-6.72) 
hybridoma  supematants  for  45  rain  at  4~  Cells  were  then 
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ment (Pel-Freez Biologicals, Brown Deer, WI) diluted 1:3. De- 
pletion ofCD4 + or CD8 + cells with the corresponding mAb was 
>90% as determined by fluorescence cytometry. Fewer than 10% 
of cells were depleted when  incubated with rabbit complement 
alone. 
Adoptive  Transfer of Spleen Cells to Nude Mice.  Spleen cell sus- 
pensions from either OvAg-sensitized or naive euthymic BALB/c 
mice were prepared after lysis of red cells with 0.05 M  Tris and 
0.75%  ammonium  chloride as described above.  2  ￿  107  viable 
cells (determined by trypan blue exclusion) were injected intra- 
peritoneally into nude recipients 1 h before intrastromal injection 
of 10 p~g OvAg. 
RNA  Extraction from Mouse  Corneas.  Corneas were dissected 
from the  eyes of five mice per group  using fine-point scissors, 
taking care that no  limbus or iris tissue  was  removed.  Corneas 
were then pooled in 500  p~l ILNAzol (Cinna/Biotecx, Friends- 
wood, TX) and homogenized on ice using micro-tissue grinders 
(Baxter Healthcare Corp.). ILNA was extracted in  10% chloro- 
form, and the aqueous phase was washed once in isopropanol and 
once in 100% ethanol and suspended in 30 Izl diethylpyrocarbon- 
ate H20.  The integrity of the ILNA was determined by agarose 
gel  electrophoresis and  detection  of 18  S  and  28  S  ribosomal 
ILNA, and RNA concentration was estimated by OD260. A pool 
of five corneas routinely yielded 3-30 ~g nucleic acid. 
Reverse Transcription (RT)-PCR of Corneal RNA.  ILNA (1 p.g) 
was  incubated at  70~  for  5  min  with  2  I-tl random  hexamer 
primers (Boehringer Mannheim Corp.). ILT reactions used 200 U 
reverse transcriptase with ILT buffer (M-MuLV;  GIBCO BILL) 
in 25 ILl volume containing 25 mM MgC12, 0.1 M  dithiothreitol, 
2.5 mM dNTPs, and 1,000 U  ILNAsin (Promega, Madison, WI). 
The mixture was incubated at 42~  for 1 h, and enzyme was then 
inactivated by  incubating at  95~  for  5  rain.  cDNA  products 
were diluted 1:6 in sterile H20. 
cDNA was amplified using 1 U  Taq DNA polymerase and 5 
p.1  PCIL  buffer  (5(10;  Promega),  25  mM  MgC12, 2.5  mM 
dNTPs, and 10 p~M sense  and antisense oligonucleotide primers 
in a final volume of 50  txl. Cycle conditions using a thermal cy- 
cler (Omnigene; National Labnet Co., Woodbridge, NJ)  were as 
follows: 1 rain at 95~  to denature double-stranded DNA, 1 min 
at 60~  to anneal primers, and 1 rain 45 s at 72~  for primer ex- 
tension. The  optimal cycle number was determined empirically 
for each set of primers using 1 p~g ILNA from anti-CD3-stimu- 
lated spleen  cells  (positive control).  By  plotting cycle number 
against  densitometry  measurements,  an  exponential  curve  was 
generated that reached a plateau at higher cycle numbers, thereby 
indicating saturation.  The  optimal cycle number  was  therefore 
defined as the number of cycles that gave a detectable signal for 
the positive control and was well below saturation level. Primer 
sequences  and  cycle  numbers  were  as  follows.  Hypoxanthine 
phosphoribosyl-transferase  (HPILT): sense, GTTGAATACAGGC- 
CAGACTTTGTTG;  antisense,  GATTCAACTTGCGCTCAT- 
CTTAGGC;  intemal,  GTTGTTGGATATGCCCTTGAC  (27 
cycles). CD4: sense, TGTGCCGAGCCATCTCTCTTAGG; anti- 
sense,  GCACTGAGAGTGTCATGCCGAAC;  internal,  CCT- 
CTCATCATCAATAAACTTAAGATGGAAG  (30 cycles). CD8: 
sense, ATGCAGCCATGGCTCTGGCTGG; antisense, GCAT- 
GTCAGGCCCTTCTGGGTC;  internal,  TTCCTGGCCTCC- 
TGGAGTTCTTCCAAAGGAG (30  cycles). IL-4: sense,  TAG- 
TTGTCATCCTGCTCTT;  antisense, C-CAGTACTACGAG- 
TAATCCA; internal, AGGGCTTCCAAGGTGCTTCGCA (30 
cycles).  IFN-~: sense,  TGTTACTGTAACGGCACAGTCATT; 
antisense, GTGGACCACTCGGATGAGCTCATT; internal, AC- 
CTCAGACTCTTTGAAGTCTTGA  (33  cycles).  CD4  and 
CD8 primer sequences were obtained from CLONTECH  (Palo 
Alto,  CA);  IL-4  antisense  and  internal sequences  were  as  de- 
scribed by  Svetic et  al.  (26);  and  other sequences  were  kindly 
provided by Dr.  Fred Heinzel. All primers were synthesized by 
Operon Technologies, Inc. (Almeda, CA), and a positive sample 
(cDNA from anti-CD3-stimulated spleen cells)  and a  negative 
sample (distilled H20) were included in each experiment. 
Southern Hybridization.  15  p.1 of the  final reaction mix was 
run in a  1.5%  agarose gel containing 0.1  p,g/ml ethidium bro- 
mide for 30 min at 150 V. Products of the positive control were 
generally  visible  by  UV  light  examination.  Double-stranded 
DNA was denatured by soaking the gel in 0.5 M NaOH in 1.5 M 
NaC1 for 1 h. NaOH was neutralized in 1 M Tris, pH 8.0, 1.5 M 
NaC1 for 1 h, and PCIL products were then transferred overnight 
to nitrocellulose (HyBond; Amersham Corp.) by capillary activ- 
ity. Products were baked onto the membrane in a vacuum oven at 
80~  for 2 h and then prehybridlzed for I h before addition of the 
FITC-deoxyuridine triphosphate-labeled probe (enhanced chemi- 
luminescence; Amersham Corp.). After overnight incubation, the 
membrane was blocked, incubated for 1 h with horseradish per- 
oxidase-labeled anti-FITC Ab, washed, and treated with chemi- 
luminescent  developer according to  the  manufacturer's  direc- 
tions. Membranes were  exposed to autoradiography film (NEF 
496;  DuPont,  Wilmington, DE).  Densitometry was  performed 
using a SciScan densitometer (United States Biochemical Corp., 
Cleveland, OH), and the fold increase was determined by the ra- 
tio of the densitometry measurement for a defined area of PCIL 
product for the experimental cornea divided by the same area for 
control cornea. 
Statistics.  Statistical analysis  was performed using Student's t 
test, and a P value of<0.05 was considered to be significant. 
Result 
Clinical and Histological  Features of OvAg-mediated Keratitis. 
Eyes of unimmunized BALB/c mice observed 7  d after in- 
trastromal injection of OvAg were similar to those of nor- 
real,  untreated  animals  in  which  no  corneal  opacities  or 
neovascularization were present (Fig. 1 A). In contrast, se- 
vere keratitis developed in mice that had been sensitized by 
immunization with OvAg before intrastromal injection. In 
the example shown in Fig.  1 B, a diffuse area of opacifica- 
tion  is  apparent,  and  neovascularization  extends  centrally 
from the limbus. 
Corneas from unimmunized mice recovered 7 d after in- 
trastromal injection of OvAg had histological features simi- 
lar to those of normal animals with distinct epithelial, stro- 
mal, and endothelial layers (Fig. 1 C). Collagen lamellae in 
the stroma were arranged in the regular, parallel configura- 
tion of the normal cornea, and resident keratocytes and oc- 
casional mononuclear cells were the only cells observed. In 
contrast,  corneas from mice that had been immunized be- 
fore intrastromal injection of OvAg developed pronounced 
stromal inflammation characterized by edema, disruption of 
collagen lamellae, and  a  profuse  cellular infiltrate that  in- 
cluded eosinophils and mononuclear cells (Fig. 1 D). 
The time course of development of keratitis in five indi- 
vidual OvAg-immunized mice  is shown  in  Fig. 2.  Opac- 
ification  progressed  rapidly  after  intrastromal  injection, 
933  Pearlman et al. Figure  1.  Macroscopic and histological 
features  of  OvAg-mediated stromal 
keratitis in BALB/c mice. BALB/c mice 
were immunized weekly three times, ei- 
ther with adjuvant  alone (Fig. 1, A and C) 
or with adjuvant  containing 10 b~g OvAg 
(Fig. 1, B and D). 1 wk after the last im- 
munization, 10  Ixg  OvAg was  injected 
into the corneal stroma. Photographs of 
intact eyes (X25) and corneal histology 
(X 1,000) are from animals  injected intra- 
stromally 10 d earlier. The upper arrow in 
Fig. 1 C delineates the external epithelial 
layer of the cornea, and the lower arrow 
indicates the  corneal endothelial layer. 
The arrows in Fig. 1 D point to eosino- 
phils in the stroma. 
reached a peak at 7-10 d,  and then gradually resolved. By 
day 21, corneas of most animals were transparent. Vascular- 
ization developed gradually, progressing over  10-14  d  to 
the center of the cornea. Neovascularization persisted after 
opacification  had  resolved.  Corneas  from  unimmunized 
mice developed mild opacification after intrastromal injec- 
tion of OvAg (stromal disease scores < 1.0), which resolved 
after 3  d.  Neovascularization did not develop in unimmu- 
nized mice. 
Spedfia'ty of OvAg-induced Keratitis.  To  determine  whether 
corneal lesions in OvAg-immunized animals were specifi- 
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Figure 2.  Temporal profile of OvAg-mediated stromal keratitis in im- 
munized BALB/c mice. Mice were immunized and injected with OvAg 
as described in the legend to Fig. 1. Eyes were examined  by sht lamp mi- 
croscopy, and corneal  opacification  was scored in increments  of 0.5 as fol- 
lows: 0, no pathology; 1.0, slight opacity; 2.0, moderate opacity; 3.0, se- 
vere opacity; and 4.0, total opacity. Neovascularization  scores are graded 
0-3.0 based on the number of vessels and the distance from the limbus. 
Results presented are of five individual  animals  from a single representa- 
tive experiment. Similar  results were obtained in eight additional  experi- 
ments. 
cally  associated  with  this  nematode  antigen  preparation, 
BALB/c  mice were  immunized and challenged intrastro- 
mally with an unrelated soluble microbial antigen prepara- 
tion, mycobacterial PPD,  using an identical protocol.  7  d 
after  intrastromal  injection,  all  of the  mice  treated  with 
OvAg developed keratitis,  with  the  intensity of reactions 
ranging from mild (1.0-2.0) to severe (>2.0) as determined 
by both opacification and neovascularization (Fig. 3 A).  In 
contrast, 7 of 15 mice treated with PPD had no detectable 
keratitis, and the remaining eight mice had mild responses. 
Stromal keratitis scores were significantly  higher for OvAg- 
treated  mice  than  for  PPD-treated  mice  (P  <0.001  for 
both opacification and neovascularization). 
LNC Proliferative and Cytokine Responses.  To character- 
ize  the  systemic Th  cell response  associated  with  stromal 
keratitis, LNC from OvAg- or PPD-immunized mice were 
incubated with homologous antigen, and cell proliferation 
and cytokine production were determined. Antigen-driven 
LNC proliferation was  not significantly different between 
the two groups. The mean -  SD stimulation index was 8.6 + 
2.0 for OvAg- and 10.1  Z  2.3  for PPD-immunized mice 
(P =  0.30), indicating that the absence of a strong inflam- 
matory response in PPD-immunized mice was not due to 
failure  to  sensitize  the  animals  compared  with  OvAg- 
treated  mice.  Indeed,  LNC  from PPD-treated mice pro- 
duced  significantly more  IFN-y  in  response  to  antigen 
stimulation than did LNC from OvAg-treated mice (means + 
SD  of five animals per group were  12.2  +  0.2 ng/ml and 
0.6 +  0.4 ng/ml, respectively, P <0.01) (Fig. 3 B). In con- 
trast, LNC from OvAg-immunized  mice produced 5.3 -+  1.3 
ng/ml IL-4 and 4.6 -+ 0.8 ng/ml IL-5, whereas PPD-treated 
934  IL-4 Requirement in Onchocercal Keratitis Figure  3.  Specificity  of keratitis  and  T  cell  re- 
sponses. Mice were  immunized and injected  intra- 
stromally either with OvAg (closed circles) or myco- 
bacterial  PPD  (open  circles) using  the  protocol 
described in the legend to Fig. 1. (A) Scores for se- 
verity ofkeratitis  7 d after corneal injection of OvAg 
were determined as described in the legend to Fig. 2. 
Results  are  combined from  three  separate experi- 
ments  with five animals per  group.  Differences in 
stromal keratitis scores between the  two groups are 
significant  (P  <0.001  for  both  opacification  and 
neovascularization). (B) LNC responses after in vitro 
stimulation  with  10  p,g/rnl  homologous  antigen. 
IFN-% IL-4,  and IL-5  were  measured by two-site 
ELISA as described in Materials and Methods.  Re- 
sults are mean +  SD of cells from five mice from a 
representative experiment.  Similar results were  ob- 
tained in two repeat experiments. 
mice  produced  <0.5  ng/ml  IL-4  and  IL-5  (P  <  0.01). 
These  data  demonstrate  a  qualitative difference in the  Th 
cell  cytokine  responses  of PPD-  and  OvAg-treated  mice 
that is consistent with induction of predominantly Thl  and 
Th2  cells,  respectively.  Total  serum  IgE  was  elevated  in 
OvAg-immunized  mice  compared  with  unimmunized 
mice (7.9  --- 2.1 vs 2.6 --- 1.0 p~g/ml, P  <0.01).  Immuniza- 
tion with PPD did not increase serum IgE. 
Spleen  cells  from  OvAg-treated  mice  had  a  cytokine 
profile similar to LNC,  producing 4.9 ng/ml IL-4 and 3.2 
ng/ml IL-5 but <0.5  ng/ml IFN-%  In vitro  depletion of 
CD4  or CD8  cells before  OvAg stimulation demonstrated 
that production of these cytokines was dependent on CD4 
cells (Fig. 4). 
T  Cell Dependence  of OvAg-mediated  Keratitis.  To deter- 
mine  if stromal  keratitis  is T  cell  dependent,  T  cell-defi- 
cient  nude  mice  were  either  immunized  subcutaneously 
and injected intrastromally with  OvAg as  described  above 
or were given spleen cells from OvAg-immunized or naive 
Figure 4.  CD4 cell dependence  of cytokine production by OvAg-im- 
munized mice. BALB/c  mice were  immunized subcutaneously and in- 
jected  intrastromally with OvAg as described in the legend  to  Fig.  1. 
Spleen cells were pooled  from five mice and depleted  of CD4 or CD8 
cells by preincubation with rat  anti-murine CD4  or anti-CD8 in the 
presence of complement.  Cytokines secreted into culture supematants af- 
ter OvAg stimulation were measured by two-site ELISA. 
BALB/c  mice  before  intrastromal  injection. As  shown  in 
Fig. 5  (le~),  OvAg-immunized nude mice did not develop 
opacification or neovascularization after intrastromal injec- 
tion. Nude mice that received cells from naive donors be- 
fore  intrastromal  injection also  failed  to  develop  keratitis 
(Fig.  5,  right,  open  circles).  However,  adoptive  transfer  of 
cells from immunized donors before  intrastromal injection 
led to development of both opacification and neovascular- 
ization (Fig.  5,  right,  closed  circles).  The  mean scores  for re- 
cipients of cells from immunized donors were  significantly 
higher than for the  other  groups  (P <0.001  for opacifica- 
tion  and  neovascularization).  Histologically,  corneal  stro- 
mas of nude mice reconstituted with cells from immunized 
euthymic mice  were  edematous  and  contained numerous 
eosinophils  and  mononuclear  cells,  whereas  stromas  of 
the  other  groups  had  no  signs  of inflammation  (data  not 
shown). 
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Figure 5.  Role ofT cells in development ofOvAg-mediated keratitis. T 
cell-deficient  nude mice  were  either  immunized subcutaneously with 
OvAg (left, closed  circles) or were given 2 ￿  107 spleen cells from either na- 
ive (right, open cirdes) or immune (right, dosed cirdes) BALB/c mice before 
intrastromal  injection.  7  d  later,  opacification  and  neovascularization 
scores were assessed as described in the legend to Fig. 2. Resuks are com- 
bined from four separate experiments with five to six mice per group. 
935  Pearlman et al. Figure 6.  T cell and cytokine gene expression  in corneas from BALB/c 
and nude mice. (/t) OvAg-immunized  BALB/c mice were injected in- 
trastromally  in one eye with OvAg as described in Materials and Methods. 
Corneas from either uninjected (left  lane) or injected (right  lane) eyes were 
removed after 3 d, RNA was extracted from a pool of five corneas, and 
expression ofCD4, CD8, IFN-% and IL-4 was determined  by RT-PCR. 
Results are representative of five similar  experiments. (B) Athymic nude 
mice were reconstituted with spleen cells from either naive (left lane) or 
immune (tight  lane) BALB/c mice before intrastromal  injection of OvAg 
as described in the legend to Fig. 5. Injected corneas were removed 3 d 
later, and gene expression  was determined by RT-PCR. Results are rep- 
resentative of three similar  experiments. 
T  Cell and  Cytokine Messenger RNA  (mRNA)  Expression 
in  Corneas from  BALB/c  and  Nude  Mice.  To  ascertain 
whether CD4 or CD8 cells were present at the site of the 
inflammatory response  and  whether  Th-associated  cyto- 
kines were produced, RNA was extracted from corneas of 
BALB/c  and nude mice and reverse  transcribed. The re- 
sulting cDNA  was  amplified by  PCR  and  examined by 
Southern  analysis.  Equivalent  amounts  of  cDNA  were 
added to  each well as  determined by Southern hybridiza- 
tion for the housekeeping gene, HPRT  (Fig. 6, A  and B). 
Consistent with  the  avascular  nature  of normal,  unin- 
flamed  corneas,  corneas  extracted  from  unimmunized 
BALB/c mice had no mRNA  expression for CD4,  CDS, 
IFN-y,  or  IL-4  (data  not  shown).  In  OvAg-immunized 
mice, corneas recovered 3  d  after intrastromal injection of 
antigen had  15-fold  elevated mRNA  expression of CD4 
and a  fivefold increase in IL-4 expression compared with 
uninjected corneas form the same animals (Fig. 6 A). CD8 
mRNA was detected in both uninjected and injected cor- 
neas  (2.1-fold  increase  in  injected  corneas),  and  IFN-y 
gene expression was low in both samples (Fig. 6 A). There 
were  no  significant differences in relative levels  of CD4, 
CD8, IFN-% or IL-4 products between corneas examined 
3  d  after intrastromal injection and those  recovered from 
mice at 7 or 10 d  (data not shown). 
Corneas were also recovered from nude mice that devel- 
oped  keratitis  after  adoptive  transfer of spleen  cells  from 
immunized BALB/c  mice and were  compared with  cor- 
neas from nude mice given naive donor cells.  As shown in 
Fig.  6  B,  OvAg-injected corneas  from  recipients  of im- 
mune donor cells had markedly elevated CD4 mRNA (15- 
fold)  and  IL-4  mRNA  (13-fold)  compared  with  corneas 
from  recipients of naive ceils.  CD8  gene  expression was 
also  elevated  (eightfold),  although  IFN-y  mRNA  levels 
were low and not elevated in reconstituted donors that de- 
veloped keratitis. 
IL-4  Requirement for  Development  of Onchocercal Keratitis. 
Because  IL-4 gene expression was  prominent in inflamed 
corneas during keratitis, we determined whether IL-4 was 
necessary for development ofonchocercal keratitis. Mice in 
which the gene for IL-4 had been selectively disrupted (IL- 
4 -/  )  were  immunized, injected with  OvAg,  and  com- 
pared with  age-  and sex-matched wild-type IL-4  +/+  nfice 
on the  same genetic background (129Sv  X  C57B1/6).  In 
some  experiments,  commercially available C57B1/6  mice 
were also included. 
IL-4  +/+  mice, but not IL-4  -/- mice, that had been im- 
munized  and  injected  intrastromally  developed  severe 
keratitis. IL-4  +/+  mice had corneal lesions similar to those 
of BALB/c mice, in which an area of opacification covered 
most of the  cornea and neovascularization extended cen- 
trally from  the  limbus (Fig.  7  A).  C57B1/6  mice immu- 
nized and injected with  OvAg developed  severe  keratitis 
that was identical to that oflL-4  +/+ mice (data not shown). 
In contrast  to  both  IL-4  +/+  and  C57B1/6  mice,  IL-4  -/- 
mice  either  failed  to  develop  keratitis  or  had  only mild, 
Figure 7.  Development of onchocercal 
keratitis in IL-4  +/+ and IL-4  -/- mice. IL- 
4  */+  and  IL-4  -/  mice were injected 
subcutaneously  and intrastromally  with 10 
p,g OvAg as described in the legend to 
Fig.  1.  A shows the  eye of an IL-4  +/+ 
mouse, and B shows the eye of an IL-4  -/ 
mouse  7  d  after intrastromal injection. 
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Figure 8.  Combined results of onchocercal keratitis in IL-4  +/+ and IL- 
4  -/- mice. Opacification and neovascularization scores of 22  IL-4  +/+ 
(closed circles) and 25 IL-4  -/- mice (open circles) from  four separate experi- 
ments are shown. All mice were immunized and injected intrastromaUy 
with 10 vtg OvAg as described in the legend to Fig. 1. Scores are from 
day 7 after  intrastromal injection (P <0.001). 
transient opacification around the site of injection. In addi- 
tion, there was no neovascularization present in corneas of 
IL-4  -/-  mice  (Fig.  7  B).  This observation was highly re- 
producible,  and the  difference in scores between  IL-4  +/+ 
and  IL-4  -/-  mice  was  significant  for  >30  animals  per 
group in four separate experiments (P <0.001,  for opacifi- 
cation and neovascularization)  (Fig.  8).  Unimmunized IL- 
4 +/+  and IL-4  -/-  mice did not develop keratitis after in- 
trastromal injection of OvAg. 
Histological examination of corneas from IL-4  +/+ mice 
showed stromal edema, an infiltrate of eosinophils, mono- 
nuclear  cells,  and  the  presence  of blood  vessels,  whereas 
corneas from IL-4  -/-  mice were  not  edematous  and  had 
only occasional inflammatory cells (data not shown). 
Discussion 
Transparency of the cornea is dependent  on an orderly 
arrangement of collagen lamellae in the stroma that allows 
light  to  pass  through  undiffracted.  Maintenance  of this 
lamellar arrangement depends on a critical level of hydra- 
tion in the stroma. During acute keratitis,  the function  of 
osmoregulatory pumps in  the  corneal  endothelium  is dis- 
rupted, resulting in stromal edema and alteration of the col- 
lagen lamellae (27).  Corneal opacification, one of the clini- 
cal hallmarks ofstromal keratitis, is caused by this change in 
the  macromolecular arrangement  of collagen  and  the  re- 
sulting  diffraction  of light.  Neovascularization,  the  other 
major feature of keratitis, is mediated by angiogenic factors 
produced  by invading inflammatory cells  and  possibly by 
resident cells of the stroma, such as keratocytes. In the cur- 
rent  study,  we  examined  the  immunopathogenesis  of 
keratitis induced by sensitization to  antigens  of the filarial 
parasite  O.  volvulus,  the  cause  of "river blindness"  in hu- 
mans. 
We found that mice injected intrastromally with  OvAg 
do not  develop  clinical  or histopathologic  changes in  the 
cornea unless they are previously sensitized to the antigen. 
This requirement for repeated and long-term exposure to 
OvAg corresponds  to  the  association between  ocular dis- 
ease and chronic infection in human onchocerciasis (8,  12). 
The pathologic changes in the corneas of mice, which in- 
clude stromal edema, opacification, neovascularization, and 
infiltration by eosinophils  and mononuclear cells,  also re- 
semble those of human disease  (5, 9). 
The  specificity  of keratitis  induced  by  OvAg  in  this 
model was  addressed by immunizing and  injecting  intra- 
stromally mycobacterial PPD, a soluble antigen preparation 
from a nonhelminthic pathogen. As judged by the capacity 
to induce and recall antigen-specific proliferation by LNC, 
OvAg and PPD were equally effective immunogens. How- 
ever,  the  duration  and  severity of clinical  and pathologic 
reactions induced by PPD were significantly less than those 
mediated by OvAg.  Comparison of the  Th  cell response 
elicited by each antigen  preparation also  showed a differ- 
ence in the pattern of cytokine production. As we reported 
previously (28),  multiple subcutaneous immunizations with 
PPD  elicit  CD4 +  T  cell  responses  indicative  of a  domi- 
nance  of the  Thl  subset;  i.e.,  Ag-driven  LNC  produce 
IFN-y but  not  IL-4  or  IL-5.  In  contrast,  immunization 
with  OvAg induces  a  CD4  Th  cell  response that  is  pre- 
dominantly Th2-1ike, with elevated IL-4 and IL-5 but rela- 
tively little  IFN-~/.  This pattern of in vitro cytokine pro- 
duction in OvAg-treated mice is consistent with observed 
in vivo responses, i.e.,  elevated serum IgE, which  is IL-4 
dependent  (29,  30),  and  eosinophil  production,  which  is 
IL-5 dependent  (31,  32).  The capacity of O.  uoluulus  anti- 
gens  to  induce  a  Th2-mediated inflammatory response is 
not unique  to  this  helminth,  as several other parasite and 
nonparasite  antigen  preparations  have been  shown  to  in- 
duce Th2-mediated inflammation (25,  33,  34).  It is more 
likely that the unique  capability of O.  volvulus  parasites to 
mediate keratitis stems from an inherent predisposition to 
invade the human cornea, thereby causing an inflammatory 
reaction in chronically infected and hyperimmunized indi- 
viduals. 
Elevated production of lgE, eosinophils, and Th2-associ- 
ated  cytokines  are  characteristic  features  of human  on- 
chocerciasis (10-15),  indicating that the murine model de- 
scribed in the current study reflects these aspects of human 
infection.  In  further  support  of an  association  between 
keratitis and Th2  responses,  OvAg-specific Th2  recall re- 
sponses were  recently reported  to  be  elevated in  persons 
with onchocercal eye disease  compared with infected indi- 
viduals without ocular manifestations of infection (12,  35). 
Although these studies measured PBMC responses, one re- 
port  examined  cytokine  gene  expression  in  conjunctival 
tissue from onchocerciasis patients and concluded that IL-4 
is  the  predominant  cytokine  expressed  in  this  site  (36). 
Consistent with this observation, we found that IL-4 gene 
expression was greatly elevated in corneas from mice with 
keratitis  compared with  uninflamed  corneas.  In  contrast, 
IFN-~/gene expression remained low in all corneas tested. 
The cellular source of IL-4 transcripts in corneas of mice 
with  OvAg-mediated  keratitis  has  not  yet  been  deter- 
mined.  IL-4 production  by OvAg-stimulated spleen  cells 
was CD4 cell dependent, and CD4 transcripts were consis- 
937  Pearlman et al. tendy elevated in corneas isolated from mice with keratitis, 
indicating  that  CD4  cells  are  the  likely  source  of IL-4. 
However, as CD8 gene expression is observed in inflamed 
corneas and  CD8  cells  stimulated in  the  presence of IL-4 
produce  Th2  cytokines  (37-39),  it  is  possible  that  CD8 
cells contribute to IL-4 production in the current study. In 
addition, IL-4 is produced by FcCRI  + cells (40-42).  In situ 
immunohistochemical  analysis  will  be necessary to  deter- 
mine the  cellular source of IL-4 production  at the  site of 
inflammation. 
Detection  of CD8  transcripts  in  inflamed  corneas  of 
OvAg-treated mice in the current study is in contrast to a 
previous immunohistologic study, which showed that CD4 
and not  CD8  cells  infiltrate  corneas of OvAg-immunized 
A/J mice (43). The discrepancy between results of this earlier 
study and the data presented here may be related to differ- 
ences in  CD8  responses determined by the  genetic  back- 
grounds of the different strains of mice, mode of immuni- 
zation  (single  vs  multiple  subcutaneous  injections),  or 
relative sensitivity of the methods to detect CD8 cells. 
As  Th2  cells  and  IL-4 are  associated with  onchocercal 
keratitis  in  both  human  infection  and  the  murine  model 
presented here, we determined ifOvAg-specific T cells and 
production of IL-4 are required for development of kerati- 
tis. The role of T  cells was examined using nude mice that 
do not have functional T  lymphocytes and do not develop 
cellular responses to filarial antigens (44, 45). Previous stud- 
ies  demonstrated  that  nude  mice  challenged  either  with 
lymphatic  filariae  (44-46)  or  injected  intravenously  with 
Schistosoma mansoni eggs (34) develop smaller inflammatory 
reactions and granulomas  compared with  euthymic  mice, 
indicating that these types of helminth-induced  pathology 
are  T  cell  dependent.  In the  current  study,  we  observed 
that sensitized T  cells are also required for development of 
onchocercal  keratitis.  First,  nude  mice  fail  to  develop 
keratitis after repeated subcutaneous immunizations and in- 
trastromal challenge with OvAg. Second, adoptive transfer 
of OvAg-sensitized  spleen  cells  from  euthymic  BALB/c 
mice to nude  mice before intrastromal injection results in 
development ofkeratitis. Adoptive transfer experiments us- 
ing OvAg-specific T  cell clones will be necessary to deter- 
mine unequivocally the relative contributions of CD4 and 
CD8 cells in mediating onchocercal keratitis. Similar stud- 
ies have been used to determine the role ofT cell subsets in 
development of murine  keratitis induced  by Herpes sim- 
plex virus (24). 
To  determine  if IL-4  is  required  for  development  of 
keratitis in the murine model, mice in which the IL-4 gene 
was genetically disrupted were studied.  These mice are de- 
ficient in their ability to produce Th2 cytokines after infec- 
tion with the nematode Nippostrongflus brasiliensis (20)  and 
have reduced  mucosal B  cell responses  to  orally adminis- 
tered antigens (47).  In the current study, we demonstrated 
that IL-4  -/- animals either fail to develop OvAg-mediated 
keratitis  or exhibit  only mild corneal  disease.  In contrast, 
IL-4  +/+ and C57B1/6 mice develop severe corneal opacifi- 
cation  and  neovascularization  after immunization  and  in- 
trastromal challenge with OvAg. 
The mechanism by which IL-4 mediates development of 
OvAg-induced keratitis is not yet known.  IL-4 has pleio- 
tropic effects on diverse cell types, including development 
of IL-4-secreting CD4 and CD8 cells  (37,  39,  48,  49)  and 
B  cell isotype switching to IgE (30,  50).  In addition,  IL-4 
increases surface expression of MHC class II and CD23 on 
B  cells  (51,  52)  and  expression  of vascular  cell  adhesion 
molecule 1 on human vascular endothelial cells (53-55).  In 
this  context,  IL-4 enhances binding and transmigration of 
eosinophils by a very late antigen 4-dependent mechanism 
(56,  57).  It is therefore possible that an important role for 
IL-4 in  keratitis  is  to  up-regulate  expression  of adhesion 
molecules on the surface of vascular and endothelial cells in 
the  limbus,  thereby  facilitating  migration  of eosinophils 
into the corneal stroma. Release of toxic eosinophil gran- 
ule proteins (58,  59)  may then disrupt the structural integ- 
rity of the cornea. Eosinophils have been reported to sur- 
round dead and dying O.  volvulus microfilariae in the skin 
of infected individuals  and to  deposit major basic  protein 
on the parasite surface  (60).  Although  the  role  of eosino- 
phil-derived  or  other  inflammatory  cell  products  in  the 
pathogenesis  of onchocercal  keratitis  is  yet  to  be  deter- 
mined, demonstration of the requirement for IL-4 suggests 
that immunological interventions that down-regulate pro- 
duction of this cytokine, such as treatment with IL-12 (61), 
may ameliorate active disease  or be useful in the design of 
antipathology vaccines. 
The authors thank Drs. W. H. Boom, F. P. Heinzel, and C. L. King for reviewing the manuscript and for 
helpful discussions. We also acknowledge the technical skills of Aviv ben Meir and Wenji Jiang for ocular 
histology, Alexander Aronshteyn for R.T-PCR.,  and Farrah Hatam for genomic  PCP,.  We are especially 
grateful to Dr. David Freedman of the University of Alabama at Birmingham for providing O. volvulus  anti- 
gen and to Dr. Ed Pearce of Cornell University for sending the IL-4  -/- and IL-4 +/+ mice. 
This work was supported by National Institutes of Health grants Al 35938 and EY 10320, by the Ohio Lions 
Foundation, and by the Research to Prevent Blindness Foundation. 
Address correspondence  to Eric Pearlman, Ph.D.,  Case Western  Reserve  University,  Division of Geo- 
graphic Medicine, School of Medicine, W137, 2109 Adelbert Road, Cleveland, OH 44106-4983. 
Received  for publication 14 February 1995 and in revised  form 27 April 1995. 
938  IL-4 Requirement in Onchocercal Keratitis References 
1.  World  Health  Organization  Expert  Committee  on  On- 
chocerciasis. 1987.  Third report.  WHO Tech. Rep.  Set.  752: 
167. 
2.  Pearlman, E., andJ.H. Lass. 1994.  Keratitis due to onchocer- 
ciasis. In Ophthalmology Clinics of North America: Intersti- 
tial Keratitis. K.R.  Wilhelmus and  T.J.  Liesegang,  editors. 
W.B. Saunders Co., Philadelphia. 641-648. 
3.  Newland,  H.S.,  A.T.  White, B.M.  Greene,  R.P.  Murphy, 
and H.R.  Taylor. 1991.  Ocular manifestations of onchocer- 
ciasis in a rain forest area of West Africa. Br. J.  Ophthalmol. 
75:163-169. 
4.  Remme,  J.,  K.Y.  Dadzie,  A.  Rolland,  and  B.  Thylefors. 
1989.  Ocular onchocerciasis and intensity of infection in the 
community. I. West African savanna.  Trop. Med. Parasitol. 40: 
340-347. 
5.  Garner, A. 1976.  Pathology of ocular onchocerciasis: human 
and  experimental.  Trans.  R.  Soc. Trop.  Med.  Hyg.  70:374- 
377. 
6.  Mackenzie, C.D., J.F. Williams, B.M. Sisley, M.W. Steward, 
and J.  O'Day.  1985.  Variations  in  host  response  and  the 
pathogenesis  of human  onchocerciasis. Rev.  Infect. Dis.  7: 
802-808. 
7.  Taylor,  H.R.,  R.P.  Murphy,  H.S.  Newland,  A.T.  White, 
S.A.  D'Anna,  L.E.  Keyvan,  M.A.  Aziz,  E.W.  Cupp,  and 
B.M. Greene. 1986.  Treatment of onchocerciasis. The ocular 
effects  of ivermectin and diethylcarbamazine. Arch.  Ophthal- 
tool. 104:863-870. 
8.  Greene,  B.M.  1990.  Onchocerciasis. In  Tropical and  Geo- 
graphical Medicine. K.S. Warren and A.F. Mahmoud,  edi- 
toes. McGraw-Hill Inc., New York. 413-422. 
9.  Chan,  C.C., E.A. Ottesen, K. Awadzi, R. Badu,  and R.B. 
Nussenblatt. 1989.  Immunopathology of ocular onchocercia- 
sis.  I.  Inflammatory  cells  infiltrating the  anterior  segment. 
Clin. Exp. Immunol.  77:367-372. 
10. Elson,  L.H.,  R.H.  Guderian,  E.  Araujo, J.E.  Bradley,  A. 
Days, and T.B. Nutman.  1994.  Immunity to onchocerciasis: 
identification of a putatively immune population in a hyper- 
endemic area of Ecuador.J. Infect. Dis.  169:588-594. 
11. Limaye, A.P., J.S. Abrams, J. Silver, K. Awadzi, H.F, Francis, 
E.A. Otteson, and T.B. Nutman. 1991.  Interleukin 5 and the 
posttreatment eosinophilia in patients with onchocerciasis.  J. 
Clin.  Invest.  88:1418-1421. 
12. McCarthy, J.S., E.A. Ottesen, and T.B. Nutman.  1994.  On- 
chocerciasis in endemic and nonendemic populations: differ- 
ences  in  clinical presentation and immunologic findings. J. 
Infect. Dis.  170:736-741. 
13. Ottesen, E.A.  1985.  Immediate hypersensitivity responses in 
the immunopathogenesis of human  onchocerciasis. Rev.  In- 
fect.  Dis. 7:796-801. 
14. Steel, C., and T.B. Nutman. 1993. Regulation of IL-5 in on- 
chocerciasis. A  critical role for IL-2. J.  Immunol.  150:5511- 
5518. 
15. Steel,  C.,  T.A.  Lujan,  P.C.  Gonzalez,  F.G.  Zea,  and  T.B. 
Nutman.  1994.  Transient  changes  in  cytokine profiles fol- 
lowing ivermectin treatment of onchocerciasis. J.  Infect. Dis. 
170:962-970. 
16. Donnelly, J.J., J.H. Rockey, A.E. Bianco, and E.J.L.  Soulsby. 
1984.  Ocular  immunopathologic  findings  of experimental 
onchocerciasis. Arch.  Ophthalmol.  102:628-634. 
17. Donnelly, J.J., J.H. Rockey, H.R. Taylor, and E.J.L, Soulsby. 
1985.  Onchocerciasis: experimental models of ocular disease. 
Rev. Infect. Dis.  7:820-825. 
939  Pearlman et al. 
18. Chakravarti,  B., J.H.  Lass, E.  Diaconu,  D.S.  Bardenstein, 
C.E.  Roy,  T.A.  Herring,  D.N.  Chakravarti,  and  B.M. 
Greene. 1993.  Immune-mediated Onchocerca votvulus scleros- 
ing keratitis in the mouse. Exp. Eye Res. 57:21-27. 
19. Gallin, M.Y., D. Murray, J.H.  Lass, H.E.  Grossniklaus, and 
B.M.  Greene.  1988.  Experimental  interstitial keratitis  in- 
duced by Onchocerca volvulus antigens. Arch.  Ophthalmol.  106: 
1447-1452. 
20. Kopf,  M.,  G.  Le  Gros,  M.  Bachmann,  M.C.  Lamers,  H. 
Bleuthmann, and G. Kohler. 1993.  Disruption of the murine 
IL-4  gene  blocks  cytokine  responses.  Nature  (Lond.).  362: 
245-247. 
21. Byars, N.E.,  and A.C. Allison. 1987.  Adjuvant formulation 
for use in vaccines to elicit both cell mediated and humoral 
immunity. Vaccine. 5:223-228. 
22. Pearlman, E.,  F.E.  Hazlett, Jr., W.H. Boom,  and J.W. Ka- 
zura.  1993.  Induction of murine T-helper-cell responses to 
the filarial nematode  Brugia malayi.  Infect. Immun.  61:1105- 
1112. 
23.  Hendricks,  R.L.,  P.C.  Weber, J.L.  Taylor,  A.  Koumbis, 
T.M. Tumpey, and J.C. Glorioso. 1991.  Endogenously pro- 
duced interferon alpha protects mice from herpes simplex vi- 
rus type 1 corneal disease.J. Gen.  Virol. 72:1601-1610. 
24. Jayaraman, S., A. Heiligenhaus, A. Rodriguez, S. Soukiasian, 
M.E.  Doff,  and C.S.  Foster.  1993.  Exacerbation of murine 
herpes simplex virus-mediated stromal keratitis by Th2  type 
T  cells.J. Immunol.  151:5777-5789. 
25. Pearlman, E., W.K. Kroeze, F.E. Hazlett, Jr., S.S. Chen, S.D. 
Mawhorter, W.H. Boom, andJ.W. Kazura. 1993.  Brugia ma- 
layi: acquired resistance to microfilariae in BALB/c mice cor- 
relates with local Th2 responses. Exp. Parasitol. 76:200-208. 
26.  Svetic,  A.,  F.D.  Finkelman, Y.C. Jian,  C.W.  Dieffenbach, 
D.E.  Scott,  K.F.  McCarthy,  A.D.  Steinberg,  and  W.C. 
Gause. 1991.  Cytokine gene expression after in vivo primary 
immunization with goat antibody to mouse IgD antibody. J. 
Immunol.  147:2391-2397. 
27. Kenyon, K.  1987.  Morphology and pathologic responses of 
the cornea to disease. In The Cornea. Scientific Foundations 
and  Clinical Practice.  G.  Smolin and R.A.  Thoft,  editors. 
Little, Brown & Co., Boston. 63-98. 
28. Pearlman,  E.,  J.W.  Kazura,  F.E.  Hazlett,  Jr.,  and  W.H. 
Boom.  1993.  Modulation of murine  cytokine responses to 
mycobacterial antigens by helminth-induced T  helper 2  cell 
responses.J. Immunol.  151:4857-4864. 
29. Katona, I.M., J.F. Urban, Jr., S.S. Kang, W.E. Paul, and F.D. 
Finkelman.  1991.  IL-4 requirements  for  the  generation of 
secondary in vivo IgE responses.J. Immunol.  146:4215-4221. 
30. Snapper, C.M., RD. Finkelman, and W.E. Paul. 1988.  Reg- 
ulation of IgG1 and IgE production by interleukin 4. Immu- 
nol. Rev. 102:51-75. 
31. Coffman, R.L., B.W. Seymour, S. Hudak, J. Jackson, and D. 
Rennick. 1989.  Antibody to interleukin-5 inhibits helminth- 
induced eosinophilia in mice. Science (Wash.  DC).  245:308- 
310. 
32. Sher, A., R.L. Coffman, S. Hieny, and A.W. Cheever. 1990. 
Ablation of eosinophil and IgE responses with anti-IL-5 or 
anti-IL-4 antibodies fails to  affect immunity against Schisto- 
soma mansoni in the mouse. J. Immunol.  145:3911-3916. 
33. Iwamoto, I., H. Nakajima, H. Endo, and S. Yoshida. 1993. 
Interferon  ~  regulates  antigen-induced  eosinophil  recruit- 
ment into the mouse airways by inhibiting the infiltration of 
CD4 + T cells.J. Exp. Med. 177:573-576. 34. Wynn,  T.A.,  I. Eltoum,  A.W. Cheever,  F.A. Lewis, W.C. 
Gause, and A. Sher.  1993.  Analysis of cytokine mRNA ex- 
pression  during  primary  granuloma  formation  induced  by 
eggs of Schistosoma mansoni.  J. Immunol. 151:1430-1440. 
35. Plier, D.A., K. Awadzi, E.M.  Keddie, and D.O.  Freedman. 
1994.  Asymptomatic  microfiladermic individuals with  on- 
chocerciasis have  relatively decreased  IL-4  and  IL-5  when 
compared to individuals with pathology. Abstracts of the 43rd 
meeting of the American Society of Tropical Medicine and Hygiene. 
51:365. 
36.  Chan, C.C., Q. Li, A.P. Brezin, S.M. Whitcup, C. Egwuagu, 
E.A.  Ottesen,  and lL.B. Nussenblatt.  1993.  Immunopathol- 
ogy of ocular onchocerciasisis III: Th-2  helper cells in the 
conjunctiva. Ocular lmmunol.  1:71-77. 
37.  Croft, M.,  L.  Carter,  S.L.  Swain,  and lL.W. Dutton.  1994. 
Generation of polarized antigen-specific CD8 effector popu- 
lations: reciprocal action of interleuldn (IL)-4 and  IL-12 in 
promoting type  2  versus  type  1  cytokine profiles. J.  Exp. 
Med.  180:1715-1728. 
38.  Salgame,  P., J.S.  Abrams,  C.  Clayberger,  H.  Goldstein, J. 
Convit, lL.L. Modlin, and B.R. Bloom. 1991. Differing lym- 
phokine profiles of functional subsets  of human  CD4  and 
CD8 T cell clones. Science (Wash. DC). 254:279-282. 
39.  Seder, IL.A., J.L. Boulay, F. Finkelman, S. Barbier, S.S. Ben, 
G.G. Le, and W.E. Paul. 1992.  CD8 + T  cells can be primed 
in vitro to produce IL-4.J. Immunol. 148:1652-1656. 
40. Ben-Sasson, S.Z., G. LeGros, D.H. Conrad, F.D. Finkelman, 
and W.E.  Paul.  1990.  Cross-linking Fc receptors stimulate 
splenic non-B, non-T cells to secrete interleukin 4 and other 
lymphokines. Proc. Natl. Acad. Sci. USA. 87:1421-1425. 
41.  Paul, W.E.,  R.A.  Seder, and M.  Plaut.  1993.  Lymphokine 
and cytokine production by Fc epsilon RI + cells. Adv. Immu- 
nol. 53:1-29. 
42. Williams, M.E.,  M.C.  Kullberg, S. Barbieri, P.  Caspar, J.A. 
Berzofsky, lL.A. Seder, and A. Sher. 1993.  Fc epsilon recep- 
tor-positive cells are a major source of antigen-induced inter- 
leukin-4 in spleens of mice infected with Schistosoma mansoni. 
Eur.J. Immunol. 23:1910-1916. 
43.  Chakravarti, B.,  T.A.  Herring, J.H.  Lass, J.S.  Parker,  R.P. 
Bucy, E. Diaconu, J.  Tseng, D.R. Whitfield, B.M.  Greene, 
and  D.N.  Chakravarti.  1994.  Infiltration of CD4 +  T  cells 
into  cornea  during  development  of Onchocerca volvulus-in- 
duced experimental sclerosing keratitis in mice. Cell. Immu- 
nol. 159:306-314. 
44.  Vickery, A.C., A.L. Vincent,  and W.J.  Sodeman.  1983.  Ef- 
fect of immune reconstitution on resistance to Brugia pahangi 
in congenitally athymic nude mice. J. ParasitoI. 69:478-485. 
45. Vickery, A.C., and A.L. Vincent.  1984.  Immunity to Brugia 
pahangi in athymic nude and normal mice: eosinophilia, anti- 
body and hypersensitivity responses.  Parasite lmmunol.  (Oxf). 
6:545-559. 
46. Vincent, A.L., A.C. Vickery, M.J. Lotz, and U. Desai. 1984. 
The lymphatic pathology of Brugia pahangi in nude (athymic) 
and thyrnic mice C3H/HeN.J.  Parasitol. 70:48-56. 
47. Vajdy, M., V.M. Kosco, M. Kopf, G. Kohler, and N. Lycke. 
1995.  Impaired mucosal immune responses in interleukin 4- 
targeted mice.J. Exp.  Med.  181:41-53. 
48.  Gross, A., S.Z. Ben-Sasson, and W.E. Paul.  1993.  Anti-IL-4 
diminishes in vivo priming for antigen-specific IL-4 produc- 
tion by T cells.J.  Immunol. 150:2112-2120. 
49. Seder, R.A., W.E. Paul, M.M. Davis, D.S. Fazekas, and B.F. 
de St.  Groth.  1992.  The presence of interleukin 4 during in 
vitro priming determines the lymphokine-producing poten- 
tial of CD4 + T  cells from T  cell receptor transgenic mice. J. 
Exp. Med.  176:1091-1098. 
50. Lebman, D.A., and R.L. Coffman. 1988. Interleukin 4 causes 
isotype switching to  IgE  in  T  cell--stimulated clonal B  cell 
cultures.J. Exp.  Med. 168:853-862. 
51.  Conrad, D.H.  1990.  Fc epsilon RII/CD23: the low affinity 
receptor for IgE. Annu. Rev. Immunol. 8:623-645. 
52.  Noelle, RJ., W.A. Kuziel, C.R. Maliszewski, E. McAdams, 
E.S. Vitetta, and P.W. Tucker.  1986.  Regulation of the ex- 
pression of multiple class II genes in murine B cells by B cell 
stimulatory factor-1 (BSF-1).J. lmmunol.  137:1718-1723. 
53.  Schleimer, IL.P., S.A. Sterbinsky, J. Kaiser, C.A. Bickel, D.A. 
Klunk,  K.  Tomioka,  W.  Newman,  F.W.  Luscinskas,  M.J. 
Gimbrone,  B.W.  Mclntyre,  and B.S.  Bochner.  1992.  IL-4 
induces adherence  of human  eosinophils and basophils but 
not neutrophils to endotheliunL Association with expression 
ofVCAM-1.J. Immunol. 148:1086-1092. 
54.  Thornhill,  M.H.,  S.M.  Wellicome,  D.L.  Mahiouz,  J.S.S. 
Lanchbury, U. Kyan-Aung, and D.O. Haskard. 1991. Tumor 
necrosis factor combines with  IL-4 or IFN-3, to selectively 
enhance endothelial cell adhesiveness for T  cells: the contri- 
bution of vascular cell adhesion molecule-l-dependent and 
independent binding mechanisms.J. Immunol. 146:592-598. 
55. Verdegaal, E.M.,  H.  Beekhuizen,  I.  Blokland,  and  R.  van 
Furth. 1993.  Increased adhesion of human monocytes to IL-4 
stimulated  venous  endothelial  cells  via  CD11/CD18  and 
VLA-4/VCAM-1 dependent mechanisms. Clin.  Exp.  Immu- 
nol. 93:292-298. 
56. Moser, R., J.  Fehr, and P.L. Bruijnzeel. 1992.  IL-4 controls 
the  selective endothelium-driven transmigration of eosino- 
phils from allergic individuals.J. Immunol. 149:1432-1438. 
57. Moser, R., P. Groscurth, J.M. Carballido, P.L. Bruijnzeel, K. 
Blaser,  C.H.  Heusser,  and J.  Fehr.  1993.  lnterleukin-4 in- 
duces tissue eosinophilia in mice: correlation with its in vitro 
capacity to stimulate the endothelial cell-dependent selective 
transmigration of human eosinophils. J.  Lab. Clin. Med.  122: 
567-575. 
58.  Trocme, S.D., and A.J. Aldave. 1994. The eye and the eosin- 
ophil. Surv. Ophthalmol. 39:241-252. 
59. Weller, P.F.  1991.  The  irnmunobiology of eosinophils. N. 
Engl, J. Med. 324:1110--1118. 
60.  Kephart,  G.M.,  G.J.  Gleich, D.H.  Connor,  D.W.  Gibson, 
and S.J. Ackerman.  1984.  Deposition of eosinophil granule 
major basic protein onto microfilariae of Onchocerca volvulus in 
the skin of patients treated with diethylcarbamazine. Lab. In- 
w'st. 50:51-61. 
61. Wynn, T.A., I. Eltoum, I.P. Oswald, A.W. Cheever, and A. 
Sher.  1994.  Endogenous  interleukin  12  (IL-12)  regulates 
granuloma formation induced by eggs of Schistosoma mansoni 
and exogenous IL-12 both inhibits and prophylactically im- 
munizes against egg pathology.J. Exp. Med.  179:1551-156. 
940  IL-4 Requirement in Onchocercal Keratitis 